These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 30278231)

  • 41. Isolevuglandin-modified phosphatidylethanolamine is metabolized by NAPE-hydrolyzing phospholipase D.
    Guo L; Gragg SD; Chen Z; Zhang Y; Amarnath V; Davies SS
    J Lipid Res; 2013 Nov; 54(11):3151-7. PubMed ID: 24018423
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular mechanisms of hypertension--reactive oxygen species and antioxidants: a basic science update for the clinician.
    Montezano AC; Touyz RM
    Can J Cardiol; 2012 May; 28(3):288-95. PubMed ID: 22445098
    [TBL] [Abstract][Full Text] [Related]  

  • 43. NADPH oxidase in the vasculature: Expression, regulation and signalling pathways; role in normal cardiovascular physiology and its dysregulation in hypertension.
    Knock GA
    Free Radic Biol Med; 2019 Dec; 145():385-427. PubMed ID: 31585207
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reactive oxygen species in vascular biology: implications in hypertension.
    Touyz RM; Schiffrin EL
    Histochem Cell Biol; 2004 Oct; 122(4):339-52. PubMed ID: 15338229
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oxidative stress, Noxs, and hypertension: experimental evidence and clinical controversies.
    Montezano AC; Touyz RM
    Ann Med; 2012 Jun; 44 Suppl 1():S2-16. PubMed ID: 22713144
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The impact of reactive oxygen species in the development of cardiometabolic disorders: a review.
    Akhigbe R; Ajayi A
    Lipids Health Dis; 2021 Feb; 20(1):23. PubMed ID: 33639960
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reactive oxygen species and vascular remodelling in hypertension: still alive.
    Xu S; Touyz RM
    Can J Cardiol; 2006 Sep; 22(11):947-51. PubMed ID: 16971980
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Accumulation of isolevuglandin-modified protein in normal and fibrotic lung.
    Mont S; Davies SS; Roberts Second LJ; Mernaugh RL; McDonald WH; Segal BH; Zackert W; Kropski JA; Blackwell TS; Sekhar KR; Galligan JJ; Massion PP; Marnett LJ; Travis EL; Freeman ML
    Sci Rep; 2016 Apr; 6():24919. PubMed ID: 27118599
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Isolevuglandins covalently modify phosphatidylethanolamines in vivo: detection and quantitative analysis of hydroxylactam adducts.
    Li W; Laird JM; Lu L; Roychowdhury S; Nagy LE; Zhou R; Crabb JW; Salomon RG
    Free Radic Biol Med; 2009 Dec; 47(11):1539-52. PubMed ID: 19751823
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inflammation, immunity, and hypertensive end-organ damage.
    McMaster WG; Kirabo A; Madhur MS; Harrison DG
    Circ Res; 2015 Mar; 116(6):1022-33. PubMed ID: 25767287
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inflammation, Lymphatics, and Cardiovascular Disease: Amplification by Chronic Kidney Disease.
    Kon V; Shelton EL; Pitzer A; Yang HC; Kirabo A
    Curr Hypertens Rep; 2022 Oct; 24(10):455-463. PubMed ID: 35727522
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dendritic cells and isolevuglandins in immunity, inflammation, and hypertension.
    Dixon KB; Davies SS; Kirabo A
    Am J Physiol Heart Circ Physiol; 2017 Mar; 312(3):H368-H374. PubMed ID: 27986660
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chronic inflammation and oxidative stress in human carcinogenesis.
    Federico A; Morgillo F; Tuccillo C; Ciardiello F; Loguercio C
    Int J Cancer; 2007 Dec; 121(11):2381-6. PubMed ID: 17893868
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Isolevuglandin-protein adducts in oxidized low density lipoprotein and human plasma: a strong connection with cardiovascular disease.
    Salomon RG; Kaur K; Batyreva E
    Trends Cardiovasc Med; 2000 Feb; 10(2):53-9. PubMed ID: 11150730
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mitochondrial Isolevuglandins Contribute to Vascular Oxidative Stress and Mitochondria-Targeted Scavenger of Isolevuglandins Reduces Mitochondrial Dysfunction and Hypertension.
    Dikalova A; Mayorov V; Xiao L; Panov A; Amarnath V; Zagol-Ikapitte I; Vergeade A; Ao M; Yermalitsky V; Nazarewicz RR; Boutaud O; Lopez MG; Billings FT; Davies S; Roberts LJ; Harrison DG; Dikalov S
    Hypertension; 2020 Dec; 76(6):1980-1991. PubMed ID: 33012204
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pretreatment with pyridoxamine mitigates isolevuglandin-associated retinal effects in mice exposed to bright light.
    Charvet CD; Saadane A; Wang M; Salomon RG; Brunengraber H; Turko IV; Pikuleva IA
    J Biol Chem; 2013 Oct; 288(41):29267-80. PubMed ID: 23970548
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cytochrome P450 1B1 gene disruption minimizes deoxycorticosterone acetate-salt-induced hypertension and associated cardiac dysfunction and renal damage in mice.
    Jennings BL; Estes AM; Anderson LJ; Fang XR; Yaghini FA; Fan Z; Gonzalez FJ; Campbell WB; Malik KU
    Hypertension; 2012 Dec; 60(6):1510-6. PubMed ID: 23108654
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Central blockade of salusin β attenuates hypertension and hypothalamic inflammation in spontaneously hypertensive rats.
    Li HB; Qin DN; Cheng K; Su Q; Miao YW; Guo J; Zhang M; Zhu GQ; Kang YM
    Sci Rep; 2015 Jul; 5():11162. PubMed ID: 26220637
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Benidipine, an anti-hypertensive drug, inhibits reactive oxygen species production in polymorphonuclear leukocytes and oxidative stress in salt-loaded stroke-prone spontaneously hypertensive rats.
    Matsubara M; Akizuki O; Ikeda J; Saeki K; Yao K; Sasaki K
    Eur J Pharmacol; 2008 Feb; 580(1-2):201-13. PubMed ID: 18048030
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Redox signaling, Nox5 and vascular remodeling in hypertension.
    Montezano AC; Tsiropoulou S; Dulak-Lis M; Harvey A; Camargo Lde L; Touyz RM
    Curr Opin Nephrol Hypertens; 2015 Sep; 24(5):425-33. PubMed ID: 26197203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.